Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT05732272
PHASE3

Improving Smoking Abstinence Outcomes in the African American Community Through Extended Treatment

Sponsor: University of Kansas Medical Center

View on ClinicalTrials.gov

Summary

This study will evaluate the efficacy of extended bupropion(6 months) versus standard bupropion treatment (7 weeks) among African American daily smokers.

Key Details

Gender

All

Age Range

18 Years - Any

Study Type

INTERVENTIONAL

Enrollment

500

Start Date

2023-02-28

Completion Date

2027-04-30

Last Updated

2026-02-23

Healthy Volunteers

Yes

Interventions

DRUG

Bupropion

150 mg once daily for 3 days, then twice daily for the remainder of the treatment phase.

Locations (1)

University of Kansas Medical Center

Kansas City, Missouri, United States